CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
93 hedge funds and large institutions have $155M invested in Cascadian Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 43 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
51% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 43
Holders
93
Holding in Top 10
2
Calls
$890K
Puts
$296K
Top Buyers
| 1 | +$18.1M | |
| 2 | +$2.87M | |
| 3 | +$2.58M | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$631K |
| 5 |
State Street
Boston,
Massachusetts
|
+$477K |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$2.51M | |
| 3 | -$1.8M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.74M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.51M |